Gene Symbol:
CTNNB1
HGNC:2514
Locus Group:
protein-coding gene
Locus Type:
gene with protein product
Location:
3p22.1
Filters:

Ambry Genetics classifications

exudative vitreoretinopathy 7
Submitted as: OMIM:617572
AD
04/19/2018
Evaluated
12/24/2020
Submitted
severe intellectual disability-progressive spastic diplegia syndrome
Submitted as: OMIM:615075
AD
05/31/2016
Evaluated
12/24/2020
Submitted

ClinGen classifications

severe intellectual disability-progressive spastic diplegia syndrome
AD
02/03/2021
Evaluated
10/18/2023
Submitted

Illumina classifications

severe intellectual disability-progressive spastic diplegia syndrome
AD
08/03/2020
Evaluated
10/15/2020
Submitted
Illumina
Evidence: CTNNB1 was first reported in relation to autosomal dominant CTNNB1-related severe intellectual disab... Read more

Invitae classifications

exudative vitreoretinopathy 7
Submitted as: OMIM:617572
AD
02/22/2023
Evaluated
11/30/2023
Submitted
severe intellectual disability-progressive spastic diplegia syndrome
Submitted as: OMIM:615075
AD
07/20/2023
Evaluated
11/30/2023
Submitted

Orphanet classifications

exudative vitreoretinopathy
Submitted as: Orphanet:891
AD
09/14/2021
Evaluated
09/14/2021
Submitted
severe intellectual disability-progressive spastic diplegia syndrome
Submitted as: Orphanet:404473
Unknown
09/14/2021
Evaluated
09/14/2021
Submitted

G2P classifications

severe intellectual disability-progressive spastic diplegia syndrome
Submitted as: OMIM:615075
AD
07/22/2015
Evaluated
09/11/2023
Submitted

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.